Notice of Intent to Grant Partially Exclusive License

Resumo

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive, license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,623,972 entitled "Detection of Presence of Chemical Precursors"; U.S. Patent No. 7,801,687 entitled "Chemical Sensors Using Coated Or Doped Carbon Nanotube Networks"; U.S. Patent No. 7,968,054 entitled "Nanostructure Sensing and Transmission of Gas Data"; U.S. Patent No. 8,000,903 entitled "Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters"; ARC-16292-1 entitled "Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations"; ARC-16902-1, entitled "Nanosensor for Medical Diagnoses"; ARC-17110-1 entitled "Detection of Gases and Vapors at Low Concentrations" to ENDO Medical Inc., having its principal place of business at 2345 Yale Street, 1st Floor, Palo Alto, CA 94306. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license